Companies
Evolva
produces fermentation-derived valencene at up to 94% purity, meeting EU flavor-ingredient regulation (EU 1334/2008) requirements for use in food and beverage applications.
- Country
- Switzerland
valencene
eu
Coverage
| CN | EU | US | |
|---|---|---|---|
| platform-chemicals | ✓ | ✓ | ✓ |
Regulatorsfdaefsareach
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | CHF 20 million initial purchase price plus up to CHF 10 million earn-out upon acquisition of Evolva AG by Danstar Ferment AG (Lallemand) in December 2023 | vegconomist.com · bakingbusiness.com · eqs-news.com |
| Capacity | Expanded through third-party contract manufacturing organizations | evonextholdings.com |
| Certification | Meets EU Flavor-ingredient regulation (EU 1334/2008) requirements for valencene purity (minimum 94%) | evonextholdings.com |
| Regulatory approval | EU 1334/2008 regulatory compliance for valencene | evonextholdings.com |
| Headquarters | Reinach, Switzerland | evonextholdings.com · eqs-news.com |
| Headcount | 48 employees (at time of acquisition) | lallemand.com |
| Revenue | CHF 6.4 million (total revenue, H1 2021); CHF 9.4 million (total revenue, 2023) | evonextholdings.com |
Independent sources: bakingbusiness.com · eqs-news.com · evonextholdings.com · lallemand.com · vegconomist.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Terpenes & terpenoids as platform molecules | platform-chemicals | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.